Advertisement
Indian
NHA announces integration of Ayushman Bharat Digital Mission with Aarogya Setu app
People can use their Ayushman Bharat Health Account number to link...
New India’s net profit at Rs 493 crore, pays Rs 866 crore of Covid claims in Q3 FY2022
Atul Sahai, CMD, New India Assurance Atul Sahai, the outgoing CMD...
ESG rater says green push compliance tough for Indian companies
The government’s move has pushed the Securities and Exchange Board...
Taxing cryptos income doesn’t make them legal: FM Sitharaman
Finance Minister Nirmala Sitharaman said, "I am not going to...
International
Vaccine likely in a few months, but life won’t return to normal until end of 2021:Dr. Fauci
“If you’re talking about getting back to a degree of normality which resembles where we were prior to Covid, it’s going to be well into 2021, maybe even towards the end of 2021,” he added.
Nearly 30 U.S. states are reporting downward trends in Covid-19 cases, but the pandemic will likely worsen again, said Fauci, the country’s leading infectious disease expert.
Aviva sells Singapore unit for $1.98 billion as new CEO shifts focus
The British company said on Friday it will sell its majority shareholding in the business to the Singlife consortium, which includes alternative asset firm TPG, Japanese insurer Sumitomo Life and other existing Singlife shareholders.
Promising to shake up the organisation after she took over in July, new CEO Amanda Blanc pledged to reduce its operations in Asia and Europe.
Analysts have said the insurer is operating in too many countries and sectors, and its shares have lagged rivals.
AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end:CEO
The pause highlights the importance of rigorous final-stage trials to pick up on potential side effects or rare events, according to Hatchett. It also shows the need to have a diversified portfolio of Covid-19 vaccines under development, a strategy that CEPI is using with its partners, he said.
“It points to the fact that vaccine development is tricky and unpredictable, and that things that look like they are going along very well can encounter difficulties,” he said.
Munich Re to stop selling Pandemic Business Coverage after losses
“We are currently examining whether we will offer new contracts that include pandemic protection in property and casualty insurance in the future,” Torsten Jeworrek, Munich Re’s head of reinsurance, said in an interview.
“For the moment it has been suspended, for example with respect to event cancellations.” The company will continue to cover pandemics in its life and health contracts.Most of Munich Re’s Covid 19-related losses this year stemmed from the scrapping of major events and other hits to companies’ income during lockdown..
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
